Member Info for Timster

Well they mentioned securing slots in conferences in the latest Q&A and AACR seems the logical one for 1a data as the full cohort 7 data will complete the set by then.

Thanks Derek doom.

So they won't mention the end of C7 or the start of the various cohorts in the 2 week study?

Could they bring it forward to before the self assessment payment on 31st Jan 😄

They could pay a company consultation fees in order to publicise the story at the right time ...... Oh wait....

If your relative was on a trial and it was proving successful. Would the first thing you do is email the daily mail?

I suppose some would as they'd want many more people to have access to it.

Heights forward selling perhaps (officially they can't but....)

Could be and they are using it as first line treatment if possible.

Are they still prepping the offer for Avacta Hurstbot?

Great research JT.

The beauty of pre|CISION I it penetrated the tumours protective barrier.

Battenburg??

Always worth remembering when eggy(thorn) posts his negative garbage that he is not invested.

The more perplexing "Why?"

Is why you post on a share you aren't invested in?

I would bet ten British pounds that they won't mention Avacta

Funding for affyxcell

https://avacta.com/affyxell-expands-its-strategic-partnership-with-genscript-probio/

Wow, good news fud team Zulu we be even more unhappy

Oh team, FUD team Zulu will not be at all happy with that!

Professor eggy isn't invested.

AACR in April would be a good target to present the 1a full data set, with cohort 7 being completed well before then.

As sonny says it's not new so doesn't require P3, P2 is a registrational study as a first line treatment.

Always worth remembering when eggy(thorn) posts his negative garbage that he is not invested, not even watched an Avacta presentation, has no idea .....